Cannabis compounds CBD and CBG may help reverse fatty liver disease, study finds – ScienceDaily
Researchers are taking a closer look at how two compounds found in cannabis plants might support liver health. A new study suggests that CBD (cannabidiol) and CBG (cannabigerol) could play a role in helping to reverse fatty liver disease, a condition that affects millions of people worldwide. The findings have generated a lot of interest in both the scientific community and among people who follow CBD and hemp research.
Fatty liver disease occurs when too much fat builds up in the liver, which can lead to serious health complications over time. Scientists involved in the study examined how CBD and CBG interacted with liver cells and found some promising signs that these compounds may help address the fat accumulation associated with the disease. While the research is still in early stages, the results point to some interesting possibilities for plant-based compounds.
CBG is often called the "parent" cannabinoid because many other cannabinoids, including CBD, are derived from it. Despite being less well-known than CBD, CBG has been gaining attention in recent years as researchers study its potential properties. This latest study adds another layer to the growing body of research exploring what these hemp-derived compounds might be capable of.
As always, anyone dealing with liver concerns or other health issues should speak with a qualified medical professional before making any changes to their routine. Studies like this one are encouraging, but more research is needed before firm conclusions can be drawn. For anyone who wants to dig into the details of this study, the full story is available through ScienceDaily.
